{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:48:54Z","timestamp":1761896934309},"reference-count":64,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["biom rep"],"DOI":"10.3892\/br.2019.1190","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T12:00:36Z","timestamp":1549368036000},"source":"Crossref","is-referenced-by-count":5,"title":["Identification of diagnostic upper gastrointestinal cancer tissue type\u2011specific urinary biomarkers"],"prefix":"10.3892","author":[{"given":"Holger","family":"Husi","sequence":"first","affiliation":[{"name":"Department of Diabetes and Cardiovascular Science, University of the Highlands and Islands, Inverness IV2 3JH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Fernandes","sequence":"additional","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Skipworth","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences and Community Health, University of Edinburgh, Edinburgh EH16 4SB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice","family":"Miller","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences and Community Health, University of Edinburgh, Edinburgh EH16 4SB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Cronshaw","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Fearon","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences and Community Health, University of Edinburgh, Edinburgh EH16 4SB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ross","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences and Community Health, University of Edinburgh, Edinburgh EH16 4SB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"key20200712183913_b1-br-0-0-1190","doi-asserted-by":"publisher","first-page":"194","DOI":"10.6004\/jnccn.2015.0028","article-title":"National comprehensive cancer network: Esophageal and esophagogastric junction cancers, version 1.2015","volume":"13","author":"Ajani","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"key20200712183913_b2-br-0-0-1190","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"Global Burden of Disease Cancer Collaboration: The Global Burden of Cancer 2013","volume":"1","author":"Fitzmaurice","year":"2015","journal-title":"JAMA Oncol"},{"key":"key20200712183913_b3-br-0-0-1190","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"EUROCARE-5 Working Group: Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE--5-a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20200712183913_b4-br-0-0-1190","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(17)31462-9","article-title":"Oesophageal cancer","volume":"390","author":"Lagergren","year":"2017","journal-title":"Lancet"},{"key":"key20200712183913_b5-br-0-0-1190","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"key20200712183913_b6-br-0-0-1190","first-page":"6","article-title":"Surprised by tears","volume":"5","author":"Kim","year":"1989","journal-title":"Christ Nurse Int"},{"key":"key20200712183913_b7-br-0-0-1190","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1002\/pmic.200700951","article-title":"Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19-9 levels in pancreatic cancer","volume":"8","author":"Grote","year":"2008","journal-title":"Proteomics"},{"key":"key20200712183913_b8-br-0-0-1190","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/CBM-2009-0134","article-title":"Positive identification of CA215 pan cancer biomarker from serum specimens of cancer patients","volume":"6","author":"Lee","year":"2010","journal-title":"Cancer Biomark"},{"key":"key20200712183913_b9-br-0-0-1190","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.4161\/cbt.7.12.6984","article-title":"Molecular identity of a pan cancer marker, CA215","volume":"7","author":"Lee","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"key20200712183913_b10-br-0-0-1190","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.3748\/wjg.14.3750","article-title":"Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma","volume":"14","author":"Zhang","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20200712183913_b11-br-0-0-1190","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1440-1746.2004.03219.x","article-title":"Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population","volume":"19","author":"Kim","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"key20200712183913_b12-br-0-0-1190","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s10620-011-1709-8","article-title":"The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma","volume":"56","author":"Singh","year":"2011","journal-title":"Dig Dis Sci"},{"key":"key20200712183913_b13-br-0-0-1190","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/CBM-2009-0610","article-title":"Cancer cell-expressed immunoglobulins: CA215 as a pan cancer marker and its diagnostic applications","volume":"5","author":"Lee","year":"2009","journal-title":"Cancer Biomark"},{"key":"key20200712183913_b14-br-0-0-1190","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1021\/pr700638k","article-title":"IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology","volume":"7","author":"Hao","year":"2008","journal-title":"J Proteome Res"},{"key":"key20200712183913_b15-br-0-0-1190","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1586\/14737159.8.5.579","article-title":"Tumor M2 pyruvate kinase: A tumor marker and its clinical application in gastrointestinal malignancy","volume":"8","author":"Hardt","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"key":"key20200712183913_b16-br-0-0-1190","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/sj.bjc.6605047","article-title":"High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer","volume":"100","author":"Gaber","year":"2009","journal-title":"Br J Cancer"},{"key":"key20200712183913_b17-br-0-0-1190","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/prca.201000107","article-title":"Proteomic analysis of urinary upper gastrointestinal cancer markers","volume":"5","author":"Husi","year":"2011","journal-title":"Proteomics Clin Appl"},{"key":"key20200712183913_b18-br-0-0-1190","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1089\/thy.2009.0400","article-title":"Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma","volume":"20","author":"Sofiadis","year":"2010","journal-title":"Thyroid"},{"key":"key20200712183913_b19-br-0-0-1190","doi-asserted-by":"publisher","first-page":"586","DOI":"10.2353\/ajpath.2010.091217","article-title":"S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer","volume":"177","author":"Wang","year":"2010","journal-title":"Am J Pathol"},{"issue":"e7670","key":"key20200712183913_b20-br-0-0-1190","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007670","article-title":"Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients","volume":"4","author":"Wei","year":"2009","journal-title":"PLoS One"},{"key":"key20200712183913_b21-br-0-0-1190","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.surg.2010.12.007","article-title":"Specific expression of osteopontin and S100A6 in hepatocellular carcinoma","volume":"149","author":"Hua","year":"2011","journal-title":"Surgery"},{"key":"key20200712183913_b22-br-0-0-1190","first-page":"172","article-title":"Increased expression of S100A6 (calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas","volume":"6","author":"Komatsu","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20200712183913_b23-br-0-0-1190","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1021\/pr7008109","article-title":"Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS","volume":"7","author":"Sanders","year":"2008","journal-title":"J Proteome Res"},{"key":"key20200712183913_b24-br-0-0-1190","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00428-007-0416-5","article-title":"Solid type clear cell carcinoma of the pancreas: differential diagnosis of an unusual case and review of the literature","volume":"450","author":"Loos","year":"2007","journal-title":"Virchows Archiv"},{"key":"key20200712183913_b25-br-0-0-1190","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00423-007-0276-0","article-title":"Molecular markers of pancreatic cancer: Development and clinical relevance","volume":"393","author":"Fry","year":"2008","journal-title":"Langenbecks Arch Surg"},{"key":"key20200712183913_b26-br-0-0-1190","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/MOU.0b013e328277f180","article-title":"Prognostic markers in renal cell carcinoma","volume":"17","author":"Ljungberg","year":"2007","journal-title":"Curr Opin Urol"},{"key":"key20200712183913_b27-br-0-0-1190","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1100\/tsw.2006.109","article-title":"Gene array studies in renal neoplasia","volume":"6","author":"Higgins","year":"2006","journal-title":"ScientificWorldJournal"},{"key":"key20200712183913_b28-br-0-0-1190","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcp.25056","article-title":"MicroRNA as Biomarkers and Diagnostics","volume":"231","author":"Wang","year":"2016","journal-title":"J Cell Physiol"},{"key":"key20200712183913_b29-br-0-0-1190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20140089","article-title":"Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers","volume":"128","author":"Lindner","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"key20200712183913_b30-br-0-0-1190","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/jama.2013.284664","article-title":"MicroRNA biomarkers in whole blood for detection of pancreatic cancer","volume":"311","author":"Schultz","year":"2014","journal-title":"JAMA"},{"issue":"555","key":"key20200712183913_b31-br-0-0-1190","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2015.555","article-title":"Metabolic serum biomarkers for the prediction of cancer: A follow-up of the studies conducted in the Swedish AMORIS study","volume":"9","author":"Bosco","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"key20200712183913_b32-br-0-0-1190","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1021\/pr501135f","article-title":"Plasma metabolite biomarkers for the detection of pancreatic cancer","volume":"14","author":"Xie","year":"2015","journal-title":"J Proteome Res"},{"key":"key20200712183913_b33-br-0-0-1190","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cca.2017.02.011","article-title":"Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC\/MS\/MS-based targeted metabolomics","volume":"468","author":"Hirata","year":"2017","journal-title":"Clin Chim Acta"},{"key":"key20200712183913_b34-br-0-0-1190","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3892\/ijo.2016.3424","article-title":"Proteomic identification of potential cancer markers in human urine using subtractive analysis","volume":"48","author":"Husi","year":"2016","journal-title":"Int J Oncol"},{"issue":"782798","key":"key20200712183913_b35-br-0-0-1190","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/782798","article-title":"Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases","volume":"2015","author":"Kalantari","year":"2015","journal-title":"Int J Proteomics"},{"key":"key20200712183913_b36-br-0-0-1190","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1631\/jzus.B0900327","article-title":"Urinary proteomics as a novel tool for biomarker discovery in kidney diseases","volume":"11","author":"Wu","year":"2010","journal-title":"J Zhejiang Univ Sci B"},{"key":"key20200712183913_b37-br-0-0-1190","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/76615","article-title":"Proteomic analysis of NMDA receptor-adhesion protein signaling complexes","volume":"3","author":"Husi","year":"2000","journal-title":"Nat Neurosci"},{"key":"key20200712183913_b38-br-0-0-1190","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1158\/1078-0432.CCR-10-0248","article-title":"Serum biomarker panels for the detection of pancreatic cancer","volume":"17","author":"Brand","year":"2011","journal-title":"Clin Cancer Research"},{"issue":"e94928","key":"key20200712183913_b39-br-0-0-1190","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094928","article-title":"Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study","volume":"9","author":"Nolen","year":"2014","journal-title":"PLoS One"},{"key":"key20200712183913_b40-br-0-0-1190","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-60761-711-2_10","article-title":"A review of experimental design best practices for proteomics based biomarker discovery: Focus on SELDI-TOF","volume":"641","author":"Caffrey","year":"2010","journal-title":"Methods Mol Biol"},{"key":"key20200712183913_b41-br-0-0-1190","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3892\/or_00000191","article-title":"Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption\/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions","volume":"21","author":"Okamoto","year":"2009","journal-title":"Oncol Rep"},{"key":"key20200712183913_b42-br-0-0-1190","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-60327-047-2_3","article-title":"Surface-enhanced laser desorption\/ionization mass spectrometry for protein and Peptide profiling of body fluids","volume":"441","author":"Gagnon","year":"2008","journal-title":"Methods Mol Biol"},{"key":"key20200712183913_b43-br-0-0-1190","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1016\/j.jchromb.2010.10.026","article-title":"Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS\/MS identification of the AACT putative urinary biomarker","volume":"878","author":"Zhang","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key20200712183913_b44-br-0-0-1190","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0021-9258(19)40178-6","article-title":"Cloning, expression, purification, and biological activity of recombinant native and variant human alpha 1-antichymotrypsins","volume":"265","author":"Rubin","year":"1990","journal-title":"J Biol Chem"},{"key":"key20200712183913_b45-br-0-0-1190","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/(SICI)1097-0215(19960529)66:5<636::AID-IJC10>3.0.CO;2-2","article-title":"Characterisation of the tumour-associated carbohydrate epitope recognised by monoclonal antibody 4D3","volume":"66","author":"Pinczower","year":"1996","journal-title":"Int J Cancer"},{"key":"key20200712183913_b46-br-0-0-1190","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1158\/1078-0432.1110.11.3","article-title":"Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins","volume":"11","author":"Koomen","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20200712183913_b47-br-0-0-1190","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1021\/pr050174l","article-title":"Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry","volume":"4","author":"Yu","year":"2005","journal-title":"J Proteome Res"},{"key":"key20200712183913_b48-br-0-0-1190","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/cncr.26270","article-title":"Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303)","volume":"118","author":"Roberts","year":"2012","journal-title":"Cancer"},{"key":"key20200712183913_b49-br-0-0-1190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00006676-200410000-00005","article-title":"Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma","volume":"29","author":"Niedergethmann","year":"2004","journal-title":"Pancreas"},{"key":"key20200712183913_b50-br-0-0-1190","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1111\/j.1349-7006.2008.00869.x","article-title":"Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth","volume":"99","author":"Hosokawa","year":"2008","journal-title":"Cancer Sci"},{"key":"key20200712183913_b51-br-0-0-1190","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1046\/j.1432-0436.2001.670406.x","article-title":"Overexpression of Hp95 induces G1 phase arrest in confluent HeLa cells","volume":"67","author":"Wu","year":"2001","journal-title":"Differentiation"},{"key":"key20200712183913_b52-br-0-0-1190","first-page":"1406","article-title":"[Screening of differentially expressed proteins from human esophageal cancer and esophageal tissues by two-dimensional difference gel electrophoresis and mass spectrometry]","volume":"27","author":"Huang","year":"2007","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"key20200712183913_b53-br-0-0-1190","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3892\/ijo_00000058","article-title":"Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma","volume":"33","author":"Hamaguchi","year":"2008","journal-title":"Int J Oncol"},{"key":"key20200712183913_b54-br-0-0-1190","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jchromb.2010.01.011","article-title":"Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry","volume":"878","author":"van den","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key20200712183913_b55-br-0-0-1190","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0002-9343(89)90224-6","article-title":"Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis","volume":"86","author":"Hack","year":"1989","journal-title":"Am J Med"},{"key":"key20200712183913_b56-br-0-0-1190","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1586\/era.10.46","article-title":"Structural and functional analysis of human prostatic acid phosphatase","volume":"10","author":"Hassan","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20200712183913_b57-br-0-0-1190","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1128\/IAI.60.11.4973-4975.1992","article-title":"Human neutrophil azurocidin synergizes with leukocyte elastase and cathepsin G in the killing of Capnocytophaga sputigena","volume":"60","author":"Miyasaki","year":"1992","journal-title":"Infect Immun"},{"key":"key20200712183913_b58-br-0-0-1190","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1021\/pr0499085","article-title":"Comprehensive proteomic analysis of human pancreatic juice","volume":"3","author":"Gr\u00f8nborg","year":"2004","journal-title":"J Proteome Res"},{"issue":"e1000227","key":"key20200712183913_b59-br-0-0-1190","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000227","article-title":"Depletion of human histone H1 variants uncovers specific roles in gene expression and cell growth","volume":"4","author":"Sancho","year":"2008","journal-title":"PLoS Genet"},{"key":"key20200712183913_b60-br-0-0-1190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/cbt.3.1.738","article-title":"Histone, H1.2: Another housekeeping protein that kills","volume":"3","author":"Zong","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"key20200712183913_b61-br-0-0-1190","doi-asserted-by":"publisher","first-page":"41690","DOI":"10.18632\/oncotarget.16677","article-title":"Cathepsins in digestive cancers","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"key20200712183913_b62-br-0-0-1190","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/prca.201300105","article-title":"Cathepsin B: Multiple roles in cancer","volume":"8","author":"Aggarwal","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"key20200712183913_b63-br-0-0-1190","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1517\/14728222.2013.740461","article-title":"Cathepsin B as a cancer target","volume":"17","author":"Gondi","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"key20200712183913_b64-br-0-0-1190","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1002\/ijc.29324","article-title":"Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity","volume":"136","author":"Madhavan","year":"2015","journal-title":"Int J Cancer"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T11:58:11Z","timestamp":1662897491000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2019.1190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":64,"URL":"https:\/\/doi.org\/10.3892\/br.2019.1190","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]}}}